Suppression of tumor progression by thioredoxin-interacting protein-dependent adenosine 2B receptor degradation in a PLAG-treated Lewis lung carcinoma-1 model of non-small cell lung cancer.
Saved in:
| Title: | Suppression of tumor progression by thioredoxin-interacting protein-dependent adenosine 2B receptor degradation in a PLAG-treated Lewis lung carcinoma-1 model of non-small cell lung cancer. |
|---|---|
| Authors: | Kim GT; Enzychem Lifesciences, 10F aT Center 27 Gangnam-daero, Seoul, South Korea., Kim EY; Enzychem Lifesciences, 10F aT Center 27 Gangnam-daero, Seoul, South Korea., Shin SH; Enzychem Lifesciences, 10F aT Center 27 Gangnam-daero, Seoul, South Korea., Lee H; Enzychem Lifesciences, 10F aT Center 27 Gangnam-daero, Seoul, South Korea., Lee SH; Enzychem Lifesciences, 10F aT Center 27 Gangnam-daero, Seoul, South Korea., Sohn KY; Enzychem Lifesciences, 10F aT Center 27 Gangnam-daero, Seoul, South Korea., Kim JW; Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Kwahak-ro, Daejeon, South Korea. Electronic address: wjkim@kribb.re.kr. |
| Source: | Neoplasia (New York, N.Y.) [Neoplasia] 2022 Sep; Vol. 31, pp. 100815. Date of Electronic Publication: 2022 Jun 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5586 (Electronic) Linking ISSN: 14765586 NLM ISO Abbreviation: Neoplasia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1476-5586 |
|---|---|
| DOI: | 10.1016/j.neo.2022.100815 |
